Correlation Between American Funds and Biotechnology Portfolio

Can any of the company-specific risk be diversified away by investing in both American Funds and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining American Funds and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between American Funds Fundamental and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on American Funds and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in American Funds with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of American Funds and Biotechnology Portfolio.

Diversification Opportunities for American Funds and Biotechnology Portfolio

0.49

Correlation Coefficient

American Funds  Biotechnology Portfolio

Very weak diversification

The 3 months correlation between American and Biotechnology is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding American Funds Fundamental and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and American Funds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on American Funds Fundamental are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of American Funds i.e., American Funds and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between American Funds and Biotechnology Portfolio

Assuming the 90 days horizon American Funds Fundamental is expected to under-perform the Biotechnology Portfolio. In addition to that, American Funds is 1.61 times more volatile than Biotechnology Portfolio Biotechnology. It trades about -0.16 of its total potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about -0.21 per unit of volatility. If you would invest  2,036  in Biotechnology Portfolio Biotechnology on October 6, 2024 and sell it today you would lose (131.00) from holding Biotechnology Portfolio Biotechnology or give up 6.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

American Funds Fundamental  vs.  Biotechnology Portfolio Biotec

American Funds Funda

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days American Funds Fundamental has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, American Funds is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with American Funds and Biotechnology Portfolio

The main advantage of trading using opposite American Funds and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if American Funds position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.

The idea behind American Funds Fundamental and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.